| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8779671 | Fertility and Sterility | 2018 | 8 Pages |
Abstract
The value of preimplantation genetic testing for aneuploidy (PGT-A) as a screening test for in vitro fertilization (IVF) patients has yet to be determined. Several studies demonstrate higher birth rates after aneuploidy testing and elective single-embryo transfer (eSET), suggesting the potential for this testing to decrease the risk of multiple gestations, though these studies have important limitations.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology,